What You Should Know:
– Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement globally, fostering stronger relationships with healthcare professionals (HCPs) through data-driven, AI-powered engagement.
– This work will support AstraZeneca’s commitment to push the boundaries of science to deliver life-changing medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology.
AstraZeneca Advances Intelligent Customer Engagement with Agentforce Life Sciences
AstraZeneca is expanding its partnership with Salesforce to usher in a new phase of intelligent, data-driven customer engagement powered by Agentforce Life Sciences. The collaboration is designed to deepen customer relationships, streamline operations, and strengthen the organization’s ability to focus on strategic outcomes that directly support patient and provider needs.
Under this broadened remit, Salesforce will deploy Agentforce 360 for Life Sciences as AstraZeneca’s unified global engagement platform. The solution will integrate medical and commercial insights to give teams shared context around healthcare professionals, improving coordination and closing information gaps across functions. It will also enable highly personalized engagement at scale, guiding key account, reimbursement, and field teams with next-best actions while automating digital campaigns across multiple channels in line with customer preferences.
AstraZeneca will further extend its composable architecture through Salesforce’s Agent Fabric and Model Context Protocol (MCP), allowing internal teams and AI agents to operate cohesively across brands, markets, and workflows. This interoperability will help orchestrate both human and machine actions across field engagement and commercial operations, building a more adaptive and intelligence-driven engagement model.
Frank Defesche, SVP and GM of Life Sciences at Salesforce, noted that AstraZeneca’s adoption of Agentforce Life Sciences marks a pivotal move toward agentic, personalized engagement across the industry. By equipping teams with advanced technology and integrated insights, the partnership aims to accelerate the delivery of transformative therapies to patients worldwide.
